ClinVar Miner

Submissions for variant NM_000256.3(MYBPC3):c.977G>A (p.Arg326Gln)

gnomAD frequency: 0.00376  dbSNP: rs34580776
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 25
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000190557 SCV000051567 benign Hypertrophic cardiomyopathy 2013-06-24 criteria provided, single submitter research
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000035689 SCV000059340 benign not specified 2010-07-08 criteria provided, single submitter clinical testing The Arg326Gln variant is thought to be a common variant found in over 5% of indi viduals from certain populations (Jaaskelainen et al. 2002, dbSNP rs34580786). T herefore, it is highly unlikely that this variant is disease-causing.
GeneDx RCV000035689 SCV000170458 benign not specified 2012-06-12 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Invitae RCV000190557 SCV000252659 benign Hypertrophic cardiomyopathy 2024-01-31 criteria provided, single submitter clinical testing
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia RCV000238837 SCV000296898 benign Dilated cardiomyopathy 1A 2015-10-31 criteria provided, single submitter clinical testing
Ambry Genetics RCV000250801 SCV000317754 benign Cardiovascular phenotype 2017-08-04 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000586999 SCV000696336 benign not provided 2016-06-06 criteria provided, single submitter clinical testing Variant summary: The MYBPC3 c.977G>A (p.Arg326Gln) variant involves the alteration of a conserved nucleotide. 2/4 in silico tools predict a benign outcome (SNPs&GO not captured due to low reliability index). This variant was found in 521/94034 control chromosomes (3 homozygotes), predominantly observed in the European (Finnish) subpopulation at a frequency of 0.015543 (77/4954). This frequency is about 16 times the estimated maximal expected allele frequency of a pathogenic MYBPC3 variant (0.0010005), suggesting this is likely a benign polymorphism found primarily in the populations of European (Finnish) origin. In addition, the variant was found to co-occur with a pathogenic MYBPC3 variant (Gln1233Ter) in two individuals (Ingles_JMG_2005 and internal LCA data), and was also found in an unaffected sister of an HCM patient (Jaaskelainen_JMM_2002). Furthermore, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Taken together, this variant is classified as benign.
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000613127 SCV000743565 benign Hypertrophic cardiomyopathy 4 2014-10-09 criteria provided, single submitter clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000613127 SCV000744858 benign Hypertrophic cardiomyopathy 4 2015-09-21 criteria provided, single submitter clinical testing
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute RCV000035689 SCV000747987 likely benign not specified 2016-10-26 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000776079 SCV000910815 benign Cardiomyopathy 2018-03-05 criteria provided, single submitter clinical testing
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego RCV000852653 SCV000995358 likely benign Primary dilated cardiomyopathy; Premature ventricular contraction 2019-03-25 criteria provided, single submitter clinical testing
Agnes Ginges Centre for Molecular Cardiology, Centenary Institute RCV000190557 SCV000996360 benign Hypertrophic cardiomyopathy 2017-09-22 criteria provided, single submitter research This variant has been identified as part of our research program. Refer to the 'condition' field for the phenotype of the proband(s) identified with this variant. For further information please feel free to contact us.
CeGaT Center for Human Genetics Tuebingen RCV000586999 SCV001148280 likely benign not provided 2024-01-01 criteria provided, single submitter clinical testing MYBPC3: BS2
Illumina Laboratory Services, Illumina RCV000613127 SCV001263316 likely benign Hypertrophic cardiomyopathy 4 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
Illumina Laboratory Services, Illumina RCV001107678 SCV001264853 benign Left ventricular noncompaction 10 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.
Fulgent Genetics, Fulgent Genetics RCV002496538 SCV002805377 likely benign Hypertrophic cardiomyopathy 4; Left ventricular noncompaction 10 2021-08-26 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000586999 SCV004563090 benign not provided 2023-10-09 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV000190557 SCV004834696 benign Hypertrophic cardiomyopathy 2024-02-05 criteria provided, single submitter clinical testing
Blueprint Genetics RCV000157304 SCV000207036 likely benign Primary familial hypertrophic cardiomyopathy 2014-05-16 no assertion criteria provided clinical testing
Blueprint Genetics RCV000157305 SCV000207037 likely benign Primary dilated cardiomyopathy 2014-05-16 no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000613127 SCV000733056 benign Hypertrophic cardiomyopathy 4 no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV000035689 SCV001919629 benign not specified no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000035689 SCV001955481 benign not specified no assertion criteria provided clinical testing
Cohesion Phenomics RCV000190557 SCV003800601 benign Hypertrophic cardiomyopathy 2022-10-10 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.